Dr. Cathy Petti Joins as Chief Health Officer to Spearhead Company's Global Health Initiatives
AncestryDNA Database Surpasses One Million People Genotyped
PROVO, Utah, July 16, 2015 (GLOBE NEWSWIRE) -- Ancestry (www.ancestry.com), the leader in family history and consumer genetics, today announced the launch of AncestryHealth (www.ancestryhealth.com), a new entity and resource to empower consumers with important health insights to help promote wellness, prevent illness and support healthier living. The company also announced appointment of Cathy A. Petti, MD, as AncestryHealth's Chief Health Officer. At the same time, AncestryDNA (www.ancestrydna.com) announced the accomplishment of surpassing one million people tested in its database.
AncestryHealth's first offering is a free service, currently in beta, that gives consumers the ability to compile their family health history information with the help of their Ancestry family tree.
Family health history is unique to every person. According to the Surgeon General's office, family health history is one of the most effective screening tools in health today. Because certain health conditions like breast cancer, heart disease and cystic fibrosis can run in families and be traced, knowing important information about one's family's health history can help individuals and their physicians be more aware of potential health problems and take the necessary steps to reduce and prevent risks.
"Ancestry fundamentally believes family history is a powerful tool that not only can educate individuals about their past and where they came from, but can inform their future," stated Tim Sullivan, CEO of Ancestry. "This new service leverages expert research and delivers customized information to consumers about the risks and prevention measures to help empower them to make healthy lifestyle choices. Combined with the breadth and scale of Ancestry data, we expect AncestryHealth to be a key piece of the puzzle as we look to understand how health is passed down through generations, and we are excited to have Dr. Petti lead this effort."
AncestryHealth integrates health information with expertise in genealogy to help consumers trace health conditions along family lines and understand what it means to individuals and their families, while recording this valuable information to share with their physicians and future generations. The company also plans to work with institutions to integrate family health history data into electronic medical records to better help physicians use family health history as a screening tool.
AncestryHealth is committed to being a partner in health by providing individuals with meaningful information and relevant research to help them make choices that could lead to longer, healthier lives. Dr. Petti joins Ancestry's strong and growing leadership team to help focus AncestryHealth's global health initiatives on empowering consumers to take charge of their health.
"We're very excited to not only launch AncestryHealth but to also have Dr. Petti join us as its Chief Health Officer," said Dr. Ken Chahine, Executive Vice President and General Manager of AncestryDNA and AncestryHealth. "This cements our commitment to bring our customers compelling, innovative and actionable health experiences. Dr. Petti brings tremendous knowledge and experience in individualized and global health, with expertise in clinical, regulatory and healthcare diagnostics. This is invaluable as we set out to create health offerings for our community that integrate with, and leverage the successes of, Ancestry and AncestryDNA."
In her role, Dr. Petti will work alongside the genomics, bioinformatics, privacy and security teams to lead a health-focused strategy and create a valuable consumer health experience, starting with AncestryHealth's family health history offering. Dr. Petti will also lead medical and regulatory affairs.
A scientific leader, Dr. Petti is internationally recognized for her expertise in clinical diagnostics and global health. Most recently, she was founder and president of HealthSpring Global, Inc., a concierge IVD consulting company supporting biotechnology companies, investors and academic researchers on the entire life cycle of advanced technologies. Dr. Petti has served as Vice President and Chief Medical Officer at TriCore Reference Laboratories; held the position of Global Head of Medical, Scientific and Clinical Affairs for Novartis Diagnostics; and was Medical Director of ARUP Laboratories. She has held appointments at leading academic institutions as a Professor of Medicine and Pathology, authored numerous peer-reviewed publications, and received multiple scientific awards and honors. Dr. Petti is board certified in both internal medicine and pathology subspecialties, and received an AB from Harvard University and MD from Duke University.
Ancestry is scaling rapidly from being the largest family history database to AncestryDNA now surpassing one million genotyped customers in just three years, making it one of the fastest growing consumer genetic networks today. Now armed with the combination of family history and DNA data, Ancestry is positioned to take a lead in giving consumers a glimpse into future possibilities. The company is also laser focused on bringing together the brightest talent, developing and designing a robust, easy-to-use platform and continuing to evolve in the health ecosystem.
To learn more about the AncestryHealth experience, visit www.ancestryhealth.com.
About Ancestry.com
Ancestry.com is the world's largest online family history resource with more than 2 million paying subscribers across all its websites. More than 16 billion records have been added, and users have created more than 70 million family trees to the core Ancestry websites, including its flagship site www.ancestry.com and its affiliated international websites. Ancestry.com offers a suite of online family history brands, including Archives.com, Fold3.com, Newspapers.com, as well as the AncestryDNA product, sold by its subsidiary, Ancestry.com DNA, LLC, and the new AncestryHealth product, offered by its subsidiary AncestryHealth.com, LLC, all of which, along with its core Ancestry websites, are designed to empower people to discover, preserve and share their family history.
About AncestryDNA
AncestryDNA is owned and operated by Ancestry.com DNA, LLC, a subsidiary of Ancestry.com, LLC. AncestryDNA uses a simple test to analyze an individual's DNA. AncestryDNA offers the potential of identifying new insights into people's ancient ancestry to help them collaborate with distant cousins and make even more discoveries in their family history. For more information visit www.ancestrydna.com.
About AncestryHealth
AncestryHealth is owned and operated by AncestryHealth.com, LLC, a subsidiary of Ancestry.com LLC. AncestryHealth helps consumers trace health conditions along family lines and gain insights based on the information provided. AncestryHealth offers users the opportunity to take charge of their health with help from their family tree. For more information visit www.ancestryhealth.com
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks and uncertainties include a variety of factors, some of which are beyond the company's control. In particular, such risks and uncertainties include the company's ability to add tools and features, and provide value to satisfy customer demand. Information concerning additional factors that could cause events or results to differ materially is contained under the caption "Risk Factors" in the Quarterly Report on Form 10-Q for Ancestry.com LLC for the period ended March 31, 2015, which was filed with the Securities and Exchange Commission on May 1, 2015, and in discussions in other of the company's Securities and Exchange Commission filings. These forward-looking statements should not be relied upon as representing our views as of any subsequent date and we assume no obligation to publicly update or revise these forward-looking statements.